IceCure Medical (ICCM) Raw Materials (2020 - 2025)

IceCure Medical (ICCM) has 6 years of Raw Materials data on file, last reported at $1.8 million in Q4 2025.

• Quarterly Raw Materials rose 28.2% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (up 28.2% YoY) and the FY2025 annual result came in at $1.8 million, up 28.2% from the prior year.
• Raw Materials advanced to $1.8 million in Q4 2025 per ICCM's latest filing, from $1.4 million in the prior quarter.
• Across five years, Raw Materials topped out at $1.8 million in Q4 2025 and bottomed at $704000.0 in Q4 2021.
• The 5-year median for Raw Materials is $1.4 million (2024), against an average of $1.4 million.
• The widest annual swing landed in 2022, when Raw Materials surged 122.44%; it then retreated 11.17% in 2023.
• Tracing ICCM's Raw Materials over 5 years: stood at $704000.0 in 2021, then jumped by 122.44% to $1.6 million in 2022, then dropped by 11.17% to $1.4 million in 2023, then grew by 1.22% to $1.4 million in 2024, then rose by 28.2% to $1.8 million in 2025.
• Per Business Quant, the three latest ICCM Raw Materials figures stand at $1.8 million (Q4 2025), $1.4 million (Q4 2024), and $1.4 million (Q4 2023).

Peer Comparison